查找临床试验
已按「卵巢癌」检索，对应国际通用词 ovarian cancer
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 10:07，每 5 分钟自动同步A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
United States、Puerto Rico
年龄 18 Years – 不限
Terremoto Biosciences Inc.
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
Sweden
年龄 18 Years – 不限
University Hospital, Linkoeping
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
United States、Japan
年龄 18 Years – 不限
Astellas Pharma Global Development, Inc.
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
United States
年龄 18 Years – 不限
City of Hope Medical Center
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
United States、France、Spain、United Kingdom
年龄 18 Years – 不限
Artios Pharma Ltd
Comprehensive Outcomes for After Cancer Health
United States
年龄 18 Years – 不限
Pack Health
Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
Canada
年龄 18 Years – 不限
Sunnybrook Health Sciences Centre
Platino-resistance in Ovarian Cancer
France
年龄 18 Years – 不限
Institut Claudius Regaud
Combined Oral Contraceptive Pill and Resistance Starch
United States
年龄 18 Years – 40 Years
University of Pennsylvania
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
United States
年龄 21 Years – 45 Years
Kaiser Permanente
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
United States、Australia、Austria、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Eli Lilly and Company
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
United States、Australia、Canada、China、Denmark 等 11 国
年龄 18 Years – 不限
Bayer